Singaporean Huang Zhenhua’s assets frozen over US$830 million suit by drug giant Novo
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying that it was misled ...
Novo Nordisk is seeking as much as US$830 million in damages in a Singapore court, saying that it was misled ...
The Danish drugmaker alleges misrepresentations by KBP Biosciences founder Huang Zhenhua about the success of its kidney drug PHARMA giant ...
THAILAND’S new government will restart negotiations with Cambodia to explore an offshore oil and gas field with at least US$300 ...
HEALTHCARE providers across the US are struggling to get paid following the week-long ransomware outage at a key tech unit ...
In December, Cometeer quietly conducted layoffs and installed its chief operating officer as co-CEO. Former employees spoke of dysfunction and ...
Forbes 40under40 stands as a distinguished platform revered for its commitment to honoring and applauding the remarkable achievements of exceptional individuals who have yet to reach the age of 40. This esteemed initiative serves as a beacon of inspiration, spotlighting trailblazers across various industries and domains, showcasing their innovation, leadership, and impact on a global scale.
© 2024 Forbes 40under40. All Rights Reserved.